StocksFin Logo
Progyny, Inc. country of incorporation
|
|
Mr. David Schlanger
|
311 employees
NASDAQ | Healthcare | Health Information Services
Neogen Corporation country of incorporation
|
|
Mr. John Adent
|
2,108 employees
NASDAQ | Healthcare | Diagnostics & Research
Q322 reported Nov 4, 2022 Reporting Period
$205.37M 67.9% vs. Q321 Revenues Q322
22.4% -3.9% vs. Q321 Gross Profit Margin
6.43% -53.2% vs. Q321 Net Profit Margin
19.65M -18.7% vs. Q321 Free Cash Flow Q322
$0.14 -26.3% vs. Q321 EPS Q322
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Q123 reported Sep 30, 2022 Reporting Period
$132.35M 3.2% vs. Q122 Revenues Q123
47.05% 0.6% vs. Q122 Gross Profit Margin
3.94% -70.4% vs. Q122 Net Profit Margin
-27.14M ! -216.9% vs. Q122 Free Cash Flow Q123
$0.05 -68.5% vs. Q122 EPS Q123
-
Period
Profitable?
Revenue Growth?
Net Profit Growth?
FCF Growth?
OCF Growth?
EPS Growth?
Pays Dividend?
Q322
Q123
Loading...
Loading...
Loading...
Loading...
Ratios
As of
Sep 30, 2022
Nov 30, 2022
Quick Ratio
2.54
2.75
Current Ratio
2.56
4.22
Cash Ratio
0.46
0.66
Price to Book
9.86
1.15
Price to Sales
16.66
15.56
Price to Earnings
64.74
-21.39